Baird raised the firm’s price target on Labcorp (LH) to $302 from $290 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $306 from $283 at Morgan Stanley
- Positive Outlook for Labcorp Holdings: Buy Rating Justified by Strong Future Prospects and Strategic Growth Initiatives
- Labcorp Reports Strong Q2 2025 Results, Raises Guidance
- Labcorp Holdings Reports Strong Growth and Raises Guidance
- Labcorp Holdings: Strong Financial Performance and Promising Outlook Justify Buy Rating